From USD 4.6 Billion to Over USD 11 Billion: How CRISPR Technologies Are Reshaping the Industry
Advancements in genome engineering have redefined the capabilities of modern biotechnology, enabling precise and efficient editing of genetic material. CRISPR and CRISPR-associated (Cas) gene systems have emerged as transformative tools that simplify complex genetic modifications and accelerate innovation across multiple scientific domains.  Increasing Adoption in Therapeutics and Research...
0 Comentários 0 Compartilhamentos